Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

Amalendu P Ranjan, Anindita Mukerjee, Lawrence Helson, Jamboor K Vishwanatha

ABSTRACT

BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch. More... »

PAGES

38

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1477-3155-10-38

DOI

http://dx.doi.org/10.1186/1477-3155-10-38

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014874253

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22937885


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Curcumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Carriers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lactic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microscopy, Confocal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Chemical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Particle Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyglycolic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Sprague-Dawley", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transcription Factor RelA", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ranjan", 
        "givenName": "Amalendu P", 
        "id": "sg:person.0702554625.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mukerjee", 
        "givenName": "Anindita", 
        "id": "sg:person.01203736343.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "SignPath Pharmaceuticals Inc, Quakertown, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helson", 
        "givenName": "Lawrence", 
        "id": "sg:person.0671324400.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Texas Health Science Center", 
          "id": "https://www.grid.ac/institutes/grid.266871.c", 
          "name": [
            "Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vishwanatha", 
        "givenName": "Jamboor K", 
        "id": "sg:person.0747516710.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1211/0022357056145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000190052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.795", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000384874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2009.04.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001694367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/29/295104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004077122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0945-053x(02)00007-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004622721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11051-010-9907-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004700764", 
          "https://doi.org/10.1007/s11051-010-9907-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2006.09.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004829869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(03)00048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004891465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005624862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-0744", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005777798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phymed.2009.04.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007104432"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(02)00127-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016356395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0957-4484/22/4/045101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2005.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019030001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10856-006-8940-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019759297", 
          "https://doi.org/10.1007/s10856-006-8940-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0378-5173(96)04854-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019942185"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2009.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021088722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-3155-5-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022264103", 
          "https://doi.org/10.1186/1477-3155-5-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-1957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022589290"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biomaterials.2010.04.062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022925716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2008.08.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024533252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0278-6915(02)00258-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025649519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.seppur.2007.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025778528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.08.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026393875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.12.043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027033711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drudis.2011.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030898701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nano.2011.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032707596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejpb.2007.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034318659"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/mp700113r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034955222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2010.03.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037770056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/cpb.54.977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039457151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0928-0987(01)00095-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041280693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp.61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044389552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tips.2009.04.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046996104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ijn.s17386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047104794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejps.2009.02.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049067143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639045.2011.563781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049089983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.powtec.2009.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051563586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bmc.1244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051768727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijpharm.2006.09.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053212930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1214/aoms/1177707047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064401263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/092986710790149738", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069161671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138920012798356952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069176048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074955168", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1211/jpp/61.03.0005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077850891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077974252", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/00224065.1980.11980968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101183642"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process.\nMETHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out.\nRESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5\u00b19.8 nm and the drug loading was determined to be 10.32\u00b11.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-\u221e) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation.\nCONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1477-3155-10-38", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7821992", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031280", 
        "issn": [
          "1477-3155"
        ], 
        "name": "Journal of Nanobiotechnology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy", 
    "pagination": "38", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22937885"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101152208"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1477-3155-10-38"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014874253"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1477-3155-10-38", 
      "https://app.dimensions.ai/details/publication/pub.1014874253"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000549.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1477-3155-10-38"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1477-3155-10-38'


 

This table displays all metadata directly associated to this object as RDF triples.

307 TRIPLES      21 PREDICATES      94 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1477-3155-10-38 schema:about N01887a815bd946dd8ed9c071c0a8d2d6
2 N0c710acfe0ec42fea400002be56f9150
3 N0cf18fbb21e94cda9bdbdb33f7c98f9a
4 N1b07c0e880734391860fd14dfee2cdd7
5 N32a64272f0d54ee0a1746da1c973c7a2
6 N50de33d98b3b42ebb71bfba331e7c085
7 N66b2aaea45074d59ad4472f49a3c0d7e
8 N6be1f0f928294cbd84e472278db8e36e
9 N8c0355dfe20f4b88ac46df853a737496
10 N8fb5e69c718e4227976bf791b74bab99
11 N9cfd79d2973842138c3b151b22246277
12 Na0717cef87544791b22666c2042666a0
13 Nb483d0b7c33d4539915ad11201f35d31
14 Nc228f0098b44494a91368929f313572a
15 Nc63233aa4ad74be5a9e0e365d8a99558
16 Nd49ebc267ac343818ead67b5cf5dec0c
17 Nda9f482c68154ec4a981f6017bc3e319
18 Ndb2656ef34ca4b61a7c976123d6d9291
19 anzsrc-for:03
20 anzsrc-for:0306
21 schema:author N09e0919bf5234c79a79c25ae0548b2ec
22 schema:citation sg:pub.10.1007/s10856-006-8940-4
23 sg:pub.10.1007/s11051-010-9907-4
24 sg:pub.10.1186/1477-3155-5-3
25 https://app.dimensions.ai/details/publication/pub.1074955168
26 https://app.dimensions.ai/details/publication/pub.1077974252
27 https://doi.org/10.1002/bmc.1244
28 https://doi.org/10.1002/bmc.795
29 https://doi.org/10.1016/j.addr.2006.09.017
30 https://doi.org/10.1016/j.biomaterials.2010.04.062
31 https://doi.org/10.1016/j.drudis.2011.09.009
32 https://doi.org/10.1016/j.ejpb.2007.09.009
33 https://doi.org/10.1016/j.ejpb.2009.02.002
34 https://doi.org/10.1016/j.ejpb.2009.06.002
35 https://doi.org/10.1016/j.ejps.2009.02.019
36 https://doi.org/10.1016/j.ijpharm.2005.12.013
37 https://doi.org/10.1016/j.ijpharm.2006.09.025
38 https://doi.org/10.1016/j.ijpharm.2006.12.043
39 https://doi.org/10.1016/j.ijpharm.2008.08.009
40 https://doi.org/10.1016/j.ijpharm.2009.04.045
41 https://doi.org/10.1016/j.ijpharm.2010.03.034
42 https://doi.org/10.1016/j.ijpharm.2010.08.033
43 https://doi.org/10.1016/j.nano.2011.07.011
44 https://doi.org/10.1016/j.phymed.2009.04.008
45 https://doi.org/10.1016/j.powtec.2009.09.004
46 https://doi.org/10.1016/j.seppur.2007.09.005
47 https://doi.org/10.1016/j.tips.2009.04.005
48 https://doi.org/10.1016/s0168-3659(02)00127-x
49 https://doi.org/10.1016/s0278-6915(02)00258-2
50 https://doi.org/10.1016/s0378-5173(96)04854-5
51 https://doi.org/10.1016/s0928-0987(01)00095-1
52 https://doi.org/10.1016/s0928-0987(03)00048-4
53 https://doi.org/10.1016/s0945-053x(02)00007-0
54 https://doi.org/10.1021/mp700113r
55 https://doi.org/10.1080/00224065.1980.11980968
56 https://doi.org/10.1088/0957-4484/22/29/295104
57 https://doi.org/10.1088/0957-4484/22/4/045101
58 https://doi.org/10.1158/1078-0432.ccr-04-0744
59 https://doi.org/10.1158/1078-0432.ccr-08-1957
60 https://doi.org/10.1211/0022357056145
61 https://doi.org/10.1211/jpp.61.03.0005
62 https://doi.org/10.1211/jpp/61.03.0005
63 https://doi.org/10.1214/aoms/1177707047
64 https://doi.org/10.1248/cpb.54.977
65 https://doi.org/10.2147/ijn.s17386
66 https://doi.org/10.2174/092986710790149738
67 https://doi.org/10.2174/138920012798356952
68 https://doi.org/10.3109/03639045.2011.563781
69 schema:datePublished 2012-12
70 schema:datePublishedReg 2012-12-01
71 schema:description BACKGROUND: Nanoparticle based delivery of anticancer drugs have been widely investigated. However, a very important process for Research & Development in any pharmaceutical industry is scaling nanoparticle formulation techniques so as to produce large batches for preclinical and clinical trials. This process is not only critical but also difficult as it involves various formulation parameters to be modulated all in the same process. METHODS: In our present study, we formulated curcumin loaded poly (lactic acid-co-glycolic acid) nanoparticles (PLGA-CURC). This improved the bioavailability of curcumin, a potent natural anticancer drug, making it suitable for cancer therapy. Post formulation, we optimized our process by Reponse Surface Methodology (RSM) using Central Composite Design (CCD) and scaled up the formulation process in four stages with final scale-up process yielding 5 g of curcumin loaded nanoparticles within the laboratory setup. The nanoparticles formed after scale-up process were characterized for particle size, drug loading and encapsulation efficiency, surface morphology, in vitro release kinetics and pharmacokinetics. Stability analysis and gamma sterilization were also carried out. RESULTS: Results revealed that that process scale-up is being mastered for elaboration to 5 g level. The mean nanoparticle size of the scaled up batch was found to be 158.5±9.8 nm and the drug loading was determined to be 10.32±1.4%. The in vitro release study illustrated a slow sustained release corresponding to 75% drug over a period of 10 days. The pharmacokinetic profile of PLGA-CURC in rats following i.v. administration showed two compartmental model with the area under the curve (AUC0-∞) being 6.139 mg/L h. Gamma sterilization showed no significant change in the particle size or drug loading of the nanoparticles. Stability analysis revealed long term physiochemical stability of the PLGA-CURC formulation. CONCLUSIONS: A successful effort towards formulating, optimizing and scaling up PLGA-CURC by using Solid-Oil/Water emulsion technique was demonstrated. The process used CCD-RSM for optimization and further scaled up to produce 5 g of PLGA-CURC with almost similar physicochemical characteristics as that of the primary formulated batch.
72 schema:genre research_article
73 schema:inLanguage en
74 schema:isAccessibleForFree true
75 schema:isPartOf N4c52a48aa2ed4790b4b02be8457caa20
76 Naf92afecf4034211a8593cd201acc8d6
77 sg:journal.1031280
78 schema:name Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy
79 schema:pagination 38
80 schema:productId N1f3bcb66350546f788a6e41dc7f0283d
81 N3b0f6ae3cfdd4e3dab058a281af7eae4
82 N40144226a1514cb8a0d6282ab3a4d637
83 N49c42399f35946f89ca725c6963c1043
84 Nd6d8fa7567fe4d98b05c5b27d4cadf71
85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014874253
86 https://doi.org/10.1186/1477-3155-10-38
87 schema:sdDatePublished 2019-04-10T15:58
88 schema:sdLicense https://scigraph.springernature.com/explorer/license/
89 schema:sdPublisher Ncffd708d3e93452db609a0617f727621
90 schema:url http://link.springer.com/10.1186%2F1477-3155-10-38
91 sgo:license sg:explorer/license/
92 sgo:sdDataset articles
93 rdf:type schema:ScholarlyArticle
94 N01887a815bd946dd8ed9c071c0a8d2d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Rats, Sprague-Dawley
96 rdf:type schema:DefinedTerm
97 N09e0919bf5234c79a79c25ae0548b2ec rdf:first sg:person.0702554625.45
98 rdf:rest Ne42162b61c114b89a7d002cf8bd16ce6
99 N0c710acfe0ec42fea400002be56f9150 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Humans
101 rdf:type schema:DefinedTerm
102 N0cf18fbb21e94cda9bdbdb33f7c98f9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Models, Chemical
104 rdf:type schema:DefinedTerm
105 N1b07c0e880734391860fd14dfee2cdd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Cell Line, Tumor
107 rdf:type schema:DefinedTerm
108 N1f3bcb66350546f788a6e41dc7f0283d schema:name doi
109 schema:value 10.1186/1477-3155-10-38
110 rdf:type schema:PropertyValue
111 N2a9467bbba024d5db4567534f2224b1f schema:name SignPath Pharmaceuticals Inc, Quakertown, PA, USA
112 rdf:type schema:Organization
113 N32a64272f0d54ee0a1746da1c973c7a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Rats
115 rdf:type schema:DefinedTerm
116 N3b0f6ae3cfdd4e3dab058a281af7eae4 schema:name pubmed_id
117 schema:value 22937885
118 rdf:type schema:PropertyValue
119 N40144226a1514cb8a0d6282ab3a4d637 schema:name dimensions_id
120 schema:value pub.1014874253
121 rdf:type schema:PropertyValue
122 N49c42399f35946f89ca725c6963c1043 schema:name nlm_unique_id
123 schema:value 101152208
124 rdf:type schema:PropertyValue
125 N4c52a48aa2ed4790b4b02be8457caa20 schema:volumeNumber 10
126 rdf:type schema:PublicationVolume
127 N50de33d98b3b42ebb71bfba331e7c085 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Curcumin
129 rdf:type schema:DefinedTerm
130 N66b2aaea45074d59ad4472f49a3c0d7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Drug Carriers
132 rdf:type schema:DefinedTerm
133 N6be1f0f928294cbd84e472278db8e36e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Particle Size
135 rdf:type schema:DefinedTerm
136 N767a47b68e7c4da4870a7bccc4deae46 rdf:first sg:person.0747516710.37
137 rdf:rest rdf:nil
138 N8c0355dfe20f4b88ac46df853a737496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Male
140 rdf:type schema:DefinedTerm
141 N8fb5e69c718e4227976bf791b74bab99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Microscopy, Confocal
143 rdf:type schema:DefinedTerm
144 N9cfd79d2973842138c3b151b22246277 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Nanoparticles
146 rdf:type schema:DefinedTerm
147 Na0717cef87544791b22666c2042666a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Research Design
149 rdf:type schema:DefinedTerm
150 Naf92afecf4034211a8593cd201acc8d6 schema:issueNumber 1
151 rdf:type schema:PublicationIssue
152 Nb483d0b7c33d4539915ad11201f35d31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Transcription Factor RelA
154 rdf:type schema:DefinedTerm
155 Nc228f0098b44494a91368929f313572a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Antineoplastic Agents
157 rdf:type schema:DefinedTerm
158 Nc63233aa4ad74be5a9e0e365d8a99558 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Polyglycolic Acid
160 rdf:type schema:DefinedTerm
161 Nc864e6df091b4a3f8589e77f021672d0 rdf:first sg:person.0671324400.35
162 rdf:rest N767a47b68e7c4da4870a7bccc4deae46
163 Ncffd708d3e93452db609a0617f727621 schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 Nd49ebc267ac343818ead67b5cf5dec0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Animals
167 rdf:type schema:DefinedTerm
168 Nd6d8fa7567fe4d98b05c5b27d4cadf71 schema:name readcube_id
169 schema:value 46ddcf245630edb02dcc6fc00efd450de7a74ee330b538a825b6df36d6b0ab84
170 rdf:type schema:PropertyValue
171 Nda9f482c68154ec4a981f6017bc3e319 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Drug Stability
173 rdf:type schema:DefinedTerm
174 Ndb2656ef34ca4b61a7c976123d6d9291 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Lactic Acid
176 rdf:type schema:DefinedTerm
177 Ne42162b61c114b89a7d002cf8bd16ce6 rdf:first sg:person.01203736343.38
178 rdf:rest Nc864e6df091b4a3f8589e77f021672d0
179 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
180 schema:name Chemical Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
183 schema:name Physical Chemistry (incl. Structural)
184 rdf:type schema:DefinedTerm
185 sg:grant.7821992 http://pending.schema.org/fundedItem sg:pub.10.1186/1477-3155-10-38
186 rdf:type schema:MonetaryGrant
187 sg:journal.1031280 schema:issn 1477-3155
188 schema:name Journal of Nanobiotechnology
189 rdf:type schema:Periodical
190 sg:person.01203736343.38 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
191 schema:familyName Mukerjee
192 schema:givenName Anindita
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203736343.38
194 rdf:type schema:Person
195 sg:person.0671324400.35 schema:affiliation N2a9467bbba024d5db4567534f2224b1f
196 schema:familyName Helson
197 schema:givenName Lawrence
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671324400.35
199 rdf:type schema:Person
200 sg:person.0702554625.45 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
201 schema:familyName Ranjan
202 schema:givenName Amalendu P
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702554625.45
204 rdf:type schema:Person
205 sg:person.0747516710.37 schema:affiliation https://www.grid.ac/institutes/grid.266871.c
206 schema:familyName Vishwanatha
207 schema:givenName Jamboor K
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747516710.37
209 rdf:type schema:Person
210 sg:pub.10.1007/s10856-006-8940-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019759297
211 https://doi.org/10.1007/s10856-006-8940-4
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s11051-010-9907-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004700764
214 https://doi.org/10.1007/s11051-010-9907-4
215 rdf:type schema:CreativeWork
216 sg:pub.10.1186/1477-3155-5-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022264103
217 https://doi.org/10.1186/1477-3155-5-3
218 rdf:type schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1074955168 schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1077974252 schema:CreativeWork
221 https://doi.org/10.1002/bmc.1244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051768727
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1002/bmc.795 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000384874
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.addr.2006.09.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004829869
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/j.biomaterials.2010.04.062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022925716
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.drudis.2011.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030898701
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.ejpb.2007.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034318659
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.ejpb.2009.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021088722
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/j.ejpb.2009.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005624862
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/j.ejps.2009.02.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049067143
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/j.ijpharm.2005.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019030001
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/j.ijpharm.2006.09.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053212930
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/j.ijpharm.2006.12.043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027033711
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/j.ijpharm.2008.08.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024533252
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1016/j.ijpharm.2009.04.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001694367
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1016/j.ijpharm.2010.03.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037770056
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1016/j.ijpharm.2010.08.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026393875
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.nano.2011.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032707596
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/j.phymed.2009.04.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007104432
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/j.powtec.2009.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051563586
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/j.seppur.2007.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025778528
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/j.tips.2009.04.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046996104
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/s0168-3659(02)00127-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016356395
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0278-6915(02)00258-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025649519
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s0378-5173(96)04854-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019942185
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/s0928-0987(01)00095-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041280693
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/s0928-0987(03)00048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004891465
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/s0945-053x(02)00007-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004622721
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1021/mp700113r schema:sameAs https://app.dimensions.ai/details/publication/pub.1034955222
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1080/00224065.1980.11980968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101183642
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1088/0957-4484/22/29/295104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004077122
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1088/0957-4484/22/4/045101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016473251
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1158/1078-0432.ccr-04-0744 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005777798
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1158/1078-0432.ccr-08-1957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022589290
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1211/0022357056145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000190052
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1211/jpp.61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044389552
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1211/jpp/61.03.0005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077850891
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1214/aoms/1177707047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064401263
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1248/cpb.54.977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039457151
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2147/ijn.s17386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047104794
298 rdf:type schema:CreativeWork
299 https://doi.org/10.2174/092986710790149738 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069161671
300 rdf:type schema:CreativeWork
301 https://doi.org/10.2174/138920012798356952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069176048
302 rdf:type schema:CreativeWork
303 https://doi.org/10.3109/03639045.2011.563781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049089983
304 rdf:type schema:CreativeWork
305 https://www.grid.ac/institutes/grid.266871.c schema:alternateName University of North Texas Health Science Center
306 schema:name Department of Molecular Biology & Immunology and Institute for Cancer Research, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, 76107, Fort Worth, TX, USA
307 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...